Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Self-citationSubcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Roach, E. S., Golomb, M. R., Adams, R., Biller, J., Daniels, S., deVeber, G., Ferriero, D., Jones, B. V., Kirkham, F. J., Scott, R. M., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.189696 · Cited by 963
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
“…dominant arteriopathy with subcortical infarcts and leukoencephalopathy, a hereditary stroke disorder) (Joutel et al., 1997a; Joutel et al., 2004; Joutel et al., 1997b; Oberstein et al., 1999) NOTCH4 ,.la te ralkS ;1002 ,.la te sinniGcM ;6002 ,.la te ovI(ainerhpozihcs ni tnemevlovni detabeD…”
BackgroundNOTCH2 Mutations Cause Alagille Syndrome, a Heterogeneous Disorder of the Notch Signaling Pathway
McDaniell, R., Warthen, D. M., Sanchez-Lara, P. A., Pai, A., Krantz, I. D., Piccoli, D. A., & Spinner, N. B. (2006) · The American Journal of Human Genetics · doi:10.1086/505332 · Cited by 749
“Examples include loss or gain of EGF-like cysteine residues in fibrillin, which results in Marfan syndrome,(16) and Notch3, which results in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).(17) The Drosophila and mammalian Notch genes are highly conserved, and both…”
BackgroundThe phenotypic spectrum of CADASIL: Clinical findings in 102 cases
Dichgans, M., Mayer, M., Uttner, I., Brüning, R., Müller‐Höcker, J., Rungger, G., Ebke, M., Klockgether, T., & Gasser, T. (1998) · Annals of Neurology · doi:10.1002/ana.410440506 · Cited by 735
Features of Alagille Syndrome in 92 Patients: Frequency and Relation to Prognosis
Emerick, K. M., Rand, E. B., Goldmuntz, E., Krantz, I. D., Spinner, N. B., & Piccoli, D. A. (1999) · Hepatology · doi:10.1002/hep.510290331 · Cited by 660
The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients
Joutel, A., Andreux, F., Gaulis, S., Domenga, V., Cecillon, M., Battail, N., Piga, N., Chapon, F., Godfrain, C., & Tournier-Lasserve, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8047 · Cited by 602
“Furthermore, mutational scanning of the Notch3 gene is hampered by the large number of exons requiring analysis (9).”
BackgroundSelf-citationHuman-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis
Fiddes, I. T., Lodewijk, G. A., Mooring, M., Bosworth, C. M., Ewing, A. D., Mantalas, G. L., Novak, A. M., van den Bout, A., Bishara, A., Rosenkrantz, J. L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.051 · Cited by 595
Dll4, a novel Notch ligand expressed in arterial endothelium
Shutter, J. R., Scully, S., Fan, W., Richards, W. G., Kitajewski, J., Deblandre, G. A., Kintner, C. R., & Stark, K. L. (2000) · Genes & Development · doi:10.1101/gad.14.11.1313 · Cited by 519
“Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a disorder that leads to ischaemic strokes and dementia in adults, and has been traced recently to missense mutations of the Notch3 receptor (Joutel et al. 1997).”
BackgroundTherapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
Regulation of vascular morphogenesis by Notch signaling
Roca, C., & Adams, R. H. (2007) · Genes & Development · doi:10.1101/gad.1589207 · Cited by 439
“The genetic defects in CADASIL are typically missense mutations, most of which translate into amino acid exchanges within the first five EGF-like repeats of the NOTCH3 ectodomain (Joutel et al. 1997).”
BackgroundBiological functions of fucose in mammals
Schneider, M., Al-Shareffi, E., & Haltiwanger, R. S. (2017) · Glycobiology · doi:10.1093/glycob/cwx034 · Cited by 431
“NOTCH3 (Q9UM47) 14/34 Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy; Myofibromatosis, infantile 2 (Joutel et al. 1997; Dichgans et al. 1999; Fouillade et al. 2008; Martignetti et al. 2013) NOTCH4 (Q99466) 18/29 — PAMR1 (Q6UXH9) 1/1 —”
Silberstein, S. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15440-8 · Cited by 420
Dichgans, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70028-5 · Cited by 397
Hassan, A. (2000) · Brain · doi:10.1093/brain/123.9.1784 · Cited by 392
Notch Signaling in Vascular Development
Iso, T., Hamamori, Y., & Kedes, L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000060892.81529.8f · Cited by 382
Joutel, A., Monet-Leprêtre, M., Gosele, C., Baron-Menguy, C., Hammes, A., Schmidt, S., Lemaire-Carrette, B., Domenga, V., Schedl, A., Lacombe, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39733 · Cited by 379
Self-citationMRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL
O’Sullivan, M., Jarosz, J. M., Martin, R. J., Deasy, N., Powell, J. F., & Markus, H. S. (2001) · Neurology · doi:10.1212/wnl.56.5.628 · Cited by 363
Diagnostic strategies in CADASIL
Markus, H. S., Martin, R. J., Simpson, M. A., Dong, Y. B., Ali, N., Crosby, A. H., & Powell, J. F. (2002) · Neurology · doi:10.1212/wnl.59.8.1134 · Cited by 335
Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
Opherk, C. (2004) · Brain · doi:10.1093/brain/awh282 · Cited by 313
“or an obligate carrier status by pedigree position (Ruchoux et al., 1995; Joutel et al., 1997; Markus et al., 2002).”
BackgroundCerebral Microbleeds in CADASIL: A Gradient-Echo Magnetic Resonance Imaging and Autopsy Study
Dichgans, M., Holtmannspötter, M., Herzog, J., Peters, N., Bergmann, M., & Yousry, T. A. (2002) · Stroke · doi:10.1161/hs0102.100885 · Cited by 293
Di Donato, I., Bianchi, S., De Stefano, N., Dichgans, M., Dotti, M. T., Duering, M., Jouvent, E., Korczyn, A. D., Lesnik-Oberstein, S. A. J., Malandrini, A., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0778-8 · Cited by 287
“More than 200 different NOTCH3 gene CADASIL-associated mutations have been reported, the majority of them consisting of stereotyped missense substitutions of a single base leading to loss or gain of a cysteine residue within one of the EGFRs of NOTCH3 extracellular domain [96].”
BackgroundVascular patterning defects associated with expression of activated Notch4 in embryonic endothelium
Uyttendaele, H., Ho, J., Rossant, J., & Kitajewski, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091584598 · Cited by 287
Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer
Dang, T. P., Gazdar, A. F., Virmani, A. K., Sepetavec, T., Hande, K. R., Minna, J. D., Roberts, J. R., & Carbone, D. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1355 · Cited by 278
Notch signaling and inherited disease syndromes
Gridley, T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg052 · Cited by 275
“Most mutations are missense mutations that are clustered near the amino terminus of the protein (53).”
BackgroundCADASIL: a Common Form of Hereditary Arteriopathy Causing Brain Infarcts and Dementia
Kalimo, H., Ruchoux, M., Viitanen, M., & Kalaria, R. N. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00451.x · Cited by 266
“Consequently, dimerization of Notch3 molecules, binding ligands, disposal of the cleaved extracellular domain and other molecular interactions may be affected (33, 38).”
BackgroundInfluentialSkin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
Joutel, A., Favrole, P., Labauge, P., Chabriat, H., Lescoat, C., Andreux, F., Domenga, V., Cécillon, M., Vahedi, K., Ducros, A., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07142-2 · Cited by 252
Self-citationJagged1 mutations in Alagille syndrome
Spinner, N. B., Colliton, R. P., Crosnier, C., Krantz, I. D., Hadchouel, M., & Meunier-Rotival, M. (2001) · Human Mutation · doi:10.1002/1098-1004(2001)17:1<18::aid-humu3>3.0.co;2-t · Cited by 233
“Most CADASIL patients have a missense mutation in NOTCH3 leading to addition or loss of a cysteine residue within one of the EGF-like repeats [Joutel et al., 1997].”
BackgroundRuchoux, M. M., Domenga, V., Brulin, P., Maciazek, J., Limol, S., Tournier-Lasserve, E., & Joutel, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63824-2 · Cited by 229
Self-citationAuer, D. P., Pütz, B., Gössl, C., Elbel, G.-K., Gasser, T., & Dichgans, M. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe24443 · Cited by 223
Notch3 establishes brain vascular integrity by regulating pericyte number
Wang, Y., Pan, L., Moens, C. B., & Appel, B. (2014) · Development · doi:10.1242/dev.096107 · Cited by 222
“…al., 2008; Liu et al., 2010; Manderfield et al., 2012; Wang et al., 2012). vSMCs and pericytes express the Notch3 receptor (Domenga et al., 2004; Joutel et al., 2000; Joutel et al., 2010) and the majority of CADASIL patients have NOTCH3 missense mutations (Joutel et al., 1996; Joutel et al., 1997).”
BackgroundMonet-Leprêtre, M., Haddad, I., Baron-Menguy, C., Fouillot-Panchal, M., Riani, M., Domenga-Denier, V., Dussaule, C., Cognat, E., Vinh, J., & Joutel, A. (2013) · Brain · doi:10.1093/brain/awt092 · Cited by 217
Self-citationEngler, A., Zhang, R., & Taylor, V. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-89512-3_11 · Cited by 216
Chabriat, H., Pappata, S., Poupon, C., Clark, C. A., Vahedi, K., Poupon, F., Mangin, J. F., Pachot-Clouard, M., Jobert, A., Le Bihan, D., et al. (1999) · Stroke · doi:10.1161/01.str.30.12.2637 · Cited by 214
Self-citationViswanathan, A. (2006) · Brain · doi:10.1093/brain/awl177 · Cited by 205
“In all cases, diagnosis was confirmed by identification of a typical mutation in the Notch3 gene (Ebke et al., 1997; Joutel et al., 1997, 2001; Dichgans et al., 2000).”
BackgroundSelf-citationRazvi, S. S. M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.051847 · Cited by 203
“Most Notch3 mutations detected so far are missense mutations affecting exon 4, with the remainder distributed amongst other exons.”
BackgroundCongruence between NOTCH3 mutations and GOM in 131 CADASIL patients
Tikka, S., Mykkänen, K., Ruchoux, M.-M., Bergholm, R., Junna, M., Pöyhönen, M., Yki-Järvinen, H., Joutel, A., Viitanen, M., Baumann, M., et al. (2009) · Brain · doi:10.1093/brain/awn364 · Cited by 203
“Thus, most diagnostic laboratories screen only the exons that according to the previous reports harbour majority of the mutations (Joutel et al., 1997; Escary et al., 2000; Kalimo et al., 2002; Opherk et al., 2004; Dotti et al., 2005).”
BackgroundSelf-citationDuering, M., Zieren, N., Hervé, D., Jouvent, E., Reyes, S., Peters, N., Pachai, C., Opherk, C., Chabriat, H., & Dichgans, M. (2011) · Brain · doi:10.1093/brain/awr169 · Cited by 200
“In all subjects, the diagnosis had been confirmed either by skin biopsy or genetic testing (Joutel et al., 1997; Peters et al., 2005).”
BackgroundSelf-citationArchetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
Rutten, J. W., Dauwerse, H. G., Gravesteijn, G., van Belzen, M. J., van der Grond, J., Polke, J. M., Bernal‐Quiros, M., & Lesnik Oberstein, S. A. J. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.344 · Cited by 200
“Arg1231Cys) have been reported in multiple CADASIL pedigrees.(12,22,23) Furthermore, more than half of the 25 mutations in ExAC have been previously reported in CADASIL pedigrees and all 25 obey the criteria used by DNA-diagnostic laboratories to establish pathogenicity of a NOTCH3 mutation.”
BackgroundJin, S., Hansson, E. M., Tikka, S., Lanner, F., Sahlgren, C., Farnebo, F., Baumann, M., Kalimo, H., & Lendahl, U. (2008) · Circulation Research · doi:10.1161/circresaha.107.167965 · Cited by 198
Beatus, P., & Lendahl, U. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981015)54:2<125::aid-jnr1>3.0.co;2-g · Cited by 143
Notch and disease: A growing field
Louvi, A., & Artavanis-Tsakonas, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.005 · Cited by 192
“They are highly stereotypical, affecting exclusively the extracellular domain and occur in exons 2–24, encoding the EGF-like repeats, with a strong clustering in exons 3 and 4 [82].”
BackgroundNovel MIR143‐NOTCH fusions in benign and malignant glomus tumors
Mosquera, J., Sboner, A., Zhang, L., Chen, C., Sung, Y., Chen, H., Agaram, N. P., Briskin, D., Basha, B. M., Singer, S., et al. (2013) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22102 · Cited by 192
“…of VSMCs. NOTCH3 loss of function mutations within the ectoplasmic domain are the genetic hallmark of CADASIL disease, which induces degeneration of cerebral VSMCs, with subsequent cerebral autosomal dominant arteriopathy, subcortical infarcts and leukoencephalopathy (Joutel et al., 1996, 1997).”
BackgroundChabriat, H., Pappata, S., Ostergaard, L., Clark, C. A., Pachot-Clouard, M., Vahedi, K., Jobert, A., Le Bihan, D., & Bousser, M. G. (2000) · Stroke · doi:10.1161/01.str.31.8.1904 · Cited by 190
Self-citationBeatus, P., Lundkvist, J., Öberg, C., & Lendahl*, U. (1999) · Development · doi:10.1242/dev.126.17.3925 · Cited by 185
The developmental biology of genetic Notch disorders
Mašek, J., & Andersson, E. R. (2017) · Development · doi:10.1242/dev.148007 · Cited by 182
“Interestingly, previous reports have described a clustering of CADASIL-related NOTCH3 mutations in exon 4 (Fig. 7B; Joutel et al., 1997), or in exon 11 (Dotti et al.”
BackgroundPeters, N., Opherk, C., Danek, A., Ballard, C., Herzog, J., & Dichgans, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2078 · Cited by 178
Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link?
Kuo, H.-K., & Lipsitz, L. A. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.8.m818 · Cited by 176
“CADASIL is caused by missense point mutations in the Notch3 gene, which encodes a transmembrane receptor protein with an important signaling function during development (36).”
BackgroundApathy: A major symptom in CADASIL
Reyes, S., Viswanathan, A., Godin, O., Dufouil, C., Benisty, S., Hernandez, K., Kurtz, A., Jouvent, E., O’Sullivan, M., Czernecki, V., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000344166.03470.f8 · Cited by 147
Self-citationNotch signaling in development and disease
Harper, J., Yuan, J., Tan, J., Visan, I., & Guidos, C. (2003) · Clinical Genetics · doi:10.1046/j.1399-0004.2003.00194.x · Cited by 147
“Virtually all CADASIL N3 mutations involve a gain or loss of a cysteine residue in one of the 34 EGF repeats in the extracellular domain (particularly clustered within the first five repeats, either by direct missense mutations or splice-site mutation) (94).”
BackgroundRutten, J. W., Van Eijsden, B. J., Duering, M., Jouvent, E., Opherk, C., Pantoni, L., Federico, A., Dichgans, M., Markus, H. S., Chabriat, H., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0088-3 · Cited by 169
Self-citationVascular dementia revisited: Diagnosis, pathogenesis, treatment, and prevention
Román, G. C. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00008-1 · Cited by 167
Joutel, A., Monet, M., Domenga, V., Riant, F., & Tournier-Lasserve, E. (2004) · The American Journal of Human Genetics · doi:10.1086/381506 · Cited by 163
“EGFR2–5, which have no predicted functional role, have been identified as forming a mutational hotspot (Joutel et al. 1997).”
BackgroundSelf-citationSpectrum of Mutations in Biopsy-Proven CADASIL: Implications for Diagnostic Strategies
Peters, N., Opherk, C., Bergmann, T., Castro, M., Herzog, J., & Dichgans, M. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1091 · Cited by 161
“However, the criteria for selecting patients and screening protocols largely varied between studies, and in none of them had the diagnosis been systematically confirmed by biopsy.(4,8,9) Thus, it is difficult to draw a conclusion about the sensitivity of genetic testing for CADASIL.”
BackgroundResultNotch3 Signaling in Vascular Smooth Muscle Cells Induces c-FLIP Expression via ERK/MAPK Activation
Wang, W., Prince, C. Z., Mou, Y., & Pollman, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202224200 · Cited by 135
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Dichgans, M. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00270-8 · Cited by 159
“All CADASIL mutations are located in EGF-like repeat domains with a strong cluster at the N-terminus [18,19].”
BackgroundInfluentialAn overview of Notch3 function in vascular smooth muscle cells
Wang, T., Baron, M., & Trump, D. (2007) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2007.07.006 · Cited by 160
“The functional importance of Notch3 in adult VSMCs is indicated by the late-onset genetic vascular condition CADASIL caused by NOTCH3 mutations (Joutel et al., 1996, 1997b), suggesting that Notch3 may have an additional role in maintaining the homeoatasis of VSMCs.”
InfluentialThe pathogenesis of cerebral small vessel disease and vascular cognitive impairment
Markus, H. S., & Joutel, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00028.2024 · Cited by 163
Self-citationModeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives
Holloway, P. M., & Gavins, F. N. E. (2016) · Stroke · doi:10.1161/strokeaha.115.011932 · Cited by 157
“exist, such as Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.(30) The”
BackgroundAlzheimer disease: Amyloidogenesis, the presenilins and animal models
Newman, M., Musgrave, I., & Lardelli, M. T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.001 · Cited by 157
Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease
Arboleda-Velasquez, J. F., Manent, J., Lee, J. H., Tikka, S., Ospina, C., Vanderburg, C. R., Frosch, M. P., Rodríguez-Falcón, M., Villen, J., Gygi, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101964108 · Cited by 138
“CADASIL mutations typically affect single extracellular cysteine residues in individual EGF-like repeats resulting in mutant receptors of unknown functionality (2, 8, 13, 19).”
BackgroundLacunar lesions are independently associated with disability and cognitive impairment in CADASIL
Viswanathan, A., Gschwendtner, A., Guichard, J. P., Buffon, F., Cumurciuc, R., O'Sullivan, M., Holtmannspötter, M., Pachai, C., Bousser, M. G., Dichgans, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000265221.05610.70 · Cited by 155
Self-citationJoutel, A., Haddad, I., Ratelade, J., & Nelson, M. T. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.62 · Cited by 128
“The majority of CADASIL mutations are missense mutations that lead to the gain or loss of a cysteine residue in the NOTCH3 extracellular domain (Notch3).(75,76) Regardless of whether they concomitantly impair NOTCH3 receptor activity, these mutations alter Notch3 itself in a way that promotes its multimerization and a…”
BackgroundSelf-citationLacombe, P., Oligo, C., Domenga, V., Tournier-Lasserve, E., & Joutel, A. (2005) · Stroke · doi:10.1161/01.str.0000163080.82766.eb · Cited by 141
Self-citationGroves, R. W., Liu, L., Dopping-Hepenstal, P. J. C., Markus, H. S., Lovell, P. A., Ozoemena, L., Lai‐Cheong, J. E., Gawler, J., Owaribe, K., Hashimoto, T., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.19 · Cited by 150
“This mutation is typical of CADASIL, in which mutations result in unpairing of a cysteine–cysteine bond in one of the epidermal growth factor-like repeats present in the extracellular portion of the transmembranous NOTCH3 protein (Joutel et al., 1997).”
BackgroundReduced Cerebrovascular CO 2 Reactivity in CADASIL: A Transcranial Doppler Sonography Study
Pfefferkorn, T., von Stuckrad-Barre, S., Herzog, J., Gasser, T., Hamann, G. F., & Dichgans, M. (2001) · Stroke · doi:10.1161/01.str.32.1.17 · Cited by 137
Joutel, A. (2011) · BioEssays · doi:10.1002/bies.201000093 · Cited by 130
“To further study the functional significance of CADASILassociated NOTCH3 mutations in a physiological context and in an unbiased way, transgenic mice expressing a human NOTCH3 protein with the WT sequence, or a representative mutation in the hotspot mutational region (R90C in EGFR2) or in the Delta/Jagged ligand-bindi…”
BackgroundInfluentialSelf-citationDichgans, M., Ludwig, H., Müller‐Höcker, J., Messerschmidt, A., & Gasser, T. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200460 · Cited by 144
Interpretation of NOTCH3 mutations in the diagnosis of CADASIL
Rutten, J. W., Haan, J., Terwindt, G. M., van Duinen, S. G., Boon, E. M., & Lesnik Oberstein, S. A. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.922880 · Cited by 124
“The prevalence of mutations in other exons varies between countries; in the French, German and English CADASIL population, exon 3 is the second most frequently mutated exon [13,53,55], whereas in Dutch CADASIL patients, exon 11 is the second most frequently mutated exon [56].”
BackgroundDistinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain
Monet-Leprêtre, M., Bardot, B., Lemaire, B., Domenga, V., Godin, O., Dichgans, M., Tournier-Lasserve, E., Cohen-Tannoudji, M., Chabriat, H., & Joutel, A. (2009) · Brain · doi:10.1093/brain/awp049 · Cited by 120
“We therefore considered only studies in which mutational scanning of all 34 EGFRs coding exons had been performed in large cohorts of patients (Joutel et al., 1997; Oberstein et al., 1999; Escary et al., 2000; Markus et al., 2002; Santa et al., 2003; Singhal et al., 2004; Dotti et al., 2005; Peters…”
InfluentialSelf-citationPathophysiology of cerebral small vessel disease: a journey through recent discoveries
Dupré, N., Drieu, A., & Joutel, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172841 · Cited by 137
“…cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), caused by dominant missense mutations that alter the number of cysteines in one of the 34 EGF repeats in the extracellular domain of the NOTCH3 protein (NOTCH3 ECD ), is the most frequent (23).”
BackgroundSelf-citationPeters, N., Opherk, C., Zacherle, S., Capell, A., Gempel, P., & Dichgans, M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.004 · Cited by 134
Prevalence and characteristics of migraine in CADASIL
Guey, S., Mawet, J., Hervé, D., Duering, M., Godin, O., Jouvent, É., Opherk, C., Alili, N., Dichgans, M., & Chabriat, H. (2016) · Cephalalgia · doi:10.1177/0333102415620909 · Cited by 132
“All patients carried a typical mutation of the NOTCH3 gene responsible for the disease or were diagnosed by the presence of pathognomonic granular osmiophilic deposits in skin biopsy (1,2).”
BackgroundSelf-citationCADASIL: A Monogenic Condition Causing Stroke and Subcortical Vascular Dementia
Dichgans, M. (2002) · Cerebrovascular Diseases · doi:10.1159/000049148 · Cited by 127
“A constant feature of Notch receptors is a large number of tandemly arranged epidermal growth factor-like (EGF-like) repeat domains which account for most of the extracellular domains of these proteins. All CADASIL mutations are located in EGF-like repeat domains of the Notch3 receptor with a strong cluster at the N-t…”
BackgroundKarlström, H., Beatus, P., Dannaeus, K., Chapman, G., Lendahl, U., & Lundkvist, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252624099 · Cited by 114
Mouse Ten-m/Odz Is a New Family of Dimeric Type II Transmembrane Proteins Expressed in Many Tissues
Oohashi, T., Zhou, X., Feng, K., Richter, B., Mörgelin, M., Perez, M. T., Su, W.-D., Chiquet‐Ehrismann, R., Rauch, U., & Fässler, R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.563 · Cited by 129
“The importance of the integrity of the cysteine patterns in EGF-like modules is exemplified by the functional impairment of notch 3, which has been observed in patients with an autosomal dominant disorder causing stroke (Joutel et al., 1997).”
BackgroundThe heritability of high myopia: a reanalysis of Goldschmidt's data
Guggenheim, J. A., KIROV, G., & HODSON, S. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.227 · Cited by 128
Damage within a network of white matter regions underlies executive dysfunction in CADASIL
O’Sullivan, M., Barrick, T. R., Morris, R. G., Clark, C. A., & Markus, H. S. (2005) · Neurology · doi:10.1212/01.wnl.0000184480.07394.fb · Cited by 114
Clinical and Genetic Aspects of CADASIL
Mizuno, T., Mizuta, I., Watanabe-Hosomi, A., Mukai, M., & Koizumi, T. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00091 · Cited by 126
“missense type, resulting in an even number to an odd number of cysteine residues (Joutel et al., 1997; Mizuta et al., 2017).”
BackgroundThe archetypal R90C CADASIL–NOTCH3 mutation retains NOTCH3 function in vivo
Monet, M., Domenga, V., Lemaire, B., Souilhol, C., Langa, F., Babinet, C., Gridley, T., Tournier-Lasserve, E., Cohen-Tannoudji, M., & Joutel, A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm042 · Cited by 109
“Moreover, prior histological analyses showed that aged TghN3(R90C) mice recapitulated the arterial defects as typically seen in CADASIL patients, including GOM deposits and NOTCH3 aggregation (23,37).”
BackgroundSelf-citationPeters, N., Herzog, J., Opherk, C., & Dichgans, M. (2004) · Stroke · doi:10.1161/01.str.0000131546.71733.f1 · Cited by 112
Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain
Yamamoto, Y., Craggs, L., Baumann, M., Kalimo, H., & Kalaria, R. N. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01147.x · Cited by 125
Liao, Y.-C., Hsiao, C.-T., Fuh, J.-L., Chern, C.-M., Lee, W.-J., Guo, Y.-C., Wang, S.-J., Lee, I.-H., Liu, Y.-T., Wang, Y.-F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136501 · Cited by 123
“Most of NOTCH3mutations are missense mutations, which usually lead to an odd number of cysteine residues and consequently a disrupted EGFR conformation [1, 3].”
BackgroundQuantitative MRI in CADASIL: Correlation with disability and cognitive performance
Dichgans, M., Filippi, M., Brüning, R., Iannucci, G., Berchtenbreiter, C., Minicucci, L., Uttner, I., Crispin, A., Ludwig, H., Gasser, T., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1361 · Cited by 120
Cortical neuronal apoptosis in CADASIL
Viswanathan, A., Gray, F., Bousser, M.-G., Baudrimont, M., & Chabriat, H. (2006) · Stroke · doi:10.1161/01.str.0000245091.28429.6a · Cited by 119
Self-citationCo-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis
Duering, M., Karpinska, A., Rosner, S., Hopfner, F., Zechmeister, M., Peters, N., Kremmer, E., Haffner, C., Giese, A., Dichgans, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr237 · Cited by 106
Molko, N., Pappata, S., Mangin, J.-F., Poupon, F., LeBihan, D., Bousser, M.-G., & Chabriat, H. (2002) · Stroke · doi:10.1161/01.str.0000041681.25514.22 · Cited by 116
Self-citationLacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL
Liem, M. K., van der Grond, J., Haan, J., van den Boom, R., Ferrari, M. D., Knaap, Y. M., Breuning, M. H., van Buchem, M. A., Middelkoop, H. A. M., & Lesnik Oberstein, S. A. J. (2007) · Stroke · doi:10.1161/01.str.0000257968.24015.bf · Cited by 114
Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy
Vahedi, K., Massin, P., Guichard, J.-P., Miocque, S., Polivka, M., Goutières, F., Dress, D., Chapon, F., Ruchoux, M.-M., Riant, F., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.57 · Cited by 107
Self-citationNotch signalling in smooth muscle cells during development and disease
Fouillade, C., Monet-Lepretre, M., Baron-Menguy, C., & Joutel, A. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs019 · Cited by 95
Self-citationNijjar, S. S., Crosby, H. A., Wallace, L., Hubscher, S. G., & Strain, A. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29399 · Cited by 106
Clinical and molecular genetics of Alagille syndrome
Krantz, I. D., Piccoli, D. A., & Spinner, N. B. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199912000-00015 · Cited by 109
CADASIL mutations enhance spontaneous multimerization of NOTCH3
Opherk, C., Duering, M., Peters, N., Karpinska, A., Rosner, S., Schneider, E., Bader, B., Giese, A., & Dichgans, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp211 · Cited by 109
Guerreiro, R. J., Lohmann, E., Kinsella, E., Brás, J. M., Luu, N., Gurunlian, N., Dursun, B., Bilgic, B., Santana, I., Hanagasi, H., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.009 · Cited by 107
“Nonetheless , p.R1231C has been repeatedly described as a cause of CADASIL (Adib-Samii et al., 2010; Joutel et al., 1997; Markus et al., 2002; Singhal et al., 2004; Ungaro et al., 2009) and because it is predicted to result in a gain of a cysteine residue, it is highly likely to be pathogenic…”
Update on genetic disorders affecting white matter
Kaye, E. M. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(00)00232-0 · Cited by 106
“[107] Joutel A, Vahedi K, Corpechot C, et al.”
BackgroundMRI correlates of cognitive decline in CADASIL: A 7-year follow-up study
Liem, M. K., Lesnik Oberstein, S. A. J., Haan, J., van der Neut, I. L., Ferrari, M. D., van Buchem, M. A., Middelkoop, H. A. M., & van der Grond, J. (2009) · Neurology · doi:10.1212/01.wnl.0000339038.65508.96 · Cited by 104
CADASIL: hereditary disease of arteries causing brain infarcts and dementia
Kalimo, Viitanen, Amberla, Juvonen, Marttila, Pöyhönen, Rinne, Savontaus, Tuisku, & Winblad (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00198.x · Cited by 94
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.